Reading what a cell is doing, from images.
Nervoid reads a cell's molecular state, its gene expression and signaling-pathway activity, directly from microscopy. We give drug-discovery and preclinical teams a fast, non-destructive way to see how a compound acts.
Our mission
Every microscopy image already carries a record of what a cell is doing. Most of that signal is left on the table. Nervoid turns those images into molecular readouts, so teams can understand mechanism and prioritize compounds without sequencing and without destroying the sample.
We treat the cell as an instrument for evaluating compounds. By reading gene expression and signaling-pathway activity straight from standard brightfield and fluorescence images, we make mechanism and toxicology readouts fast enough to use at screening scale.
Where we are
Our platform runs through an API that is already integrated into a partner's screening workflow. Results return in seconds per run, alongside the assays teams already use.
We work with drug-discovery and preclinical scientists on phenotypic hit prioritization, mechanism-of-action readouts, and toxicology.
The team
Built by a cell biologist and an ML engineer working at the boundary of microscopy and molecular biology.